Abnormal behavior
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Finally, we demonstrated that in utero gene therapy for Pqbp1-cKO mice by intraperitoneal injection of the PQBP1-AAV vector at E10 successfully rescued microcephaly with preserved cortical structures and improved behavioral abnormalities in Pqbp1-cKO mice, opening a new strategy for treating this intractable developmental disorder.
|
25070536 |
2015 |
Abnormal behavior
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
These results suggested that PQBP1 dysfunction in regulating gene expression might underlie the abnormal behavior and cognition of PQBP1-KD mice and that the recovery of expression of such PQBP1 target genes might improve the symptoms in adult patients.
|
19661183 |
2009 |
Abnormality of the rib cage
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired Camptodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.
|
30283027 |
2018 |
Ankylosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anus, Imperforate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Arachnodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Asthma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Interactions between GST genotypes and SHS exposure or asthma severity with the study outcomes were nonsignificant.
|
29785881 |
2018 |
Atrial Septal Defects
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Atrial Septal Defects
|
0.400 |
Biomarker
|
group |
CTD_human |
Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene.
|
16740914 |
2006 |
Autosomal Recessive Hereditary Spastic Paraplegia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation.
|
14634649 |
2003 |
Blindness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Brachycephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Brittle hair
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bulbous nose
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bulbous nose
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
The three patients of the first family displayed the typical features underlying PQBP1 such as the long triangular face, bulbous nose, hypoplastic malar region, and micrognathia, which were subsequently confirmed using targeted sequence analysis that showed a previously reported nonsense mutation c.586C>T p.R196*.
|
30244542 |
2018 |
Byzanthine arch palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Childhood Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Accordingly, PQBP1 and PCK2 are crucial for recurrence and metastasis in OS, and these findings provide a molecular basis for the exploitation of diagnostic and therapeutic strategies for overcoming recurrence and metastasis in OS.
|
31205570 |
2019 |
Class III malocclusion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Clinodactyly of the 5th finger
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|